Effect of intraoperative dobutamine on splanchnic tissue perfusion and outcome after Whipple surgery

Journal of Critical Care

Volumn 28, Issue 4, 2013, Pages 531.e7-531.e15

  Reyad, Amal Rashad ^a   Elkharboutly, Walaa ^a   Wahba, Ashraf ^a   Elmorshedi, Mohamed ^a   Hasaneen, Nadia A ^a  

^a MANSOURA UNIVERSITY   (Egypt)

Author keywords

Dobutamine; Gastric mucosal tonometry; Splanchnic perfusion; Whipple's surgery

Indexed keywords

BUPIVACAINE; DOBUTAMINE; FENTANYL; MIDAZOLAM; MORPHINE; PARACETAMOL; RANITIDINE; THIOPENTAL; VECURONIUM; CARDIOTONIC AGENT; PLACEBO;

ABDOMINAL SURGERY; ADULT; ANESTHESIA INDUCTION; ARTICLE; ARTIFICIAL VENTILATION; CONTROLLED STUDY; DOUBLE BLIND PROCEDURE; ELECTROCARDIOGRAPHY; ENDOTRACHEAL INTUBATION; GASTRIC TONOMETER; HEART RATE; HEART VENTRICLE EXTRASYSTOLE; HEMODYNAMIC PARAMETERS; HUMAN; INCIDENCE; INTRAOPERATIVE PERIOD; ISCHEMIA; MAJOR CLINICAL STUDY; MEAN ARTERIAL PRESSURE; MORBIDITY; MORTALITY; OXYGEN SATURATION; PANCREATICODUODENECTOMY; PH; POSTOPERATIVE COMPLICATION; PROSPECTIVE STUDY; RANDOMIZED CONTROLLED TRIAL; SPLANCHNIC BLOOD FLOW; STOMACH MUCOSA; TISSUE PERFUSION; TREATMENT OUTCOME; ANALYSIS OF VARIANCE; BLOOD GAS ANALYSIS; CONTROLLED CLINICAL TRIAL; DRUG EFFECT; FEMALE; GASTRIC MUCOSAL TONOMETRY; HEMODYNAMICS; MALE; NONPARAMETRIC TEST; PEROPERATIVE CARE; SPLANCHNIC PERFUSION; WHIPPLE'S SURGERY;

DOBUTAMINE; GASTRIC MUCOSAL TONOMETRY; SPLANCHNIC PERFUSION; WHIPPLE'S SURGERY;

ADULT; ANALYSIS OF VARIANCE; BLOOD GAS ANALYSIS; CARDIOTONIC AGENTS; DOBUTAMINE; DOUBLE-BLIND METHOD; FEMALE; HEMODYNAMICS; HUMANS; HYDROGEN-ION CONCENTRATION; INTRAOPERATIVE CARE; MALE; PANCREATICODUODENECTOMY; PLACEBOS; SPLANCHNIC CIRCULATION; STATISTICS, NONPARAMETRIC;

EID: 84886707760     PISSN: 08839441     EISSN: 15578615     Source Type: Journal    
DOI: 10.1016/j.jcrc.2013.02.017     Document Type: Article

References (41)

1. Ohri S.K., Velissaris T. Gastrointestinal dysfunction following cardiac surgery. Perfusion 2006, 21(4):215-223.
2. Paparella D., Yau T.M., Young E. Cardiopulmonary bypass induced inflammation: pathophysiology and treatment. An update. Eur J Cardiothorac Surg 2002, 21(2):232-244.
3. Mythen M.G. Postoperative gastrointestinal tract dysfunction. Anesth Analg 2005, 100(1):196-204.
4. Tsunooka N., Maeyama K., Hamada Y., Imagawa H., Takano S., et al. Bacterial translocation secondary to small intestinal mucosal ischemia during cardiopulmonary bypass. Measurement by diamine oxidase and peptidoglycan. Eur J Cardiothorac Surg 2004, 25(2):275-280.
5. Jansen N.J., van Oeveren W., Gu Y.J., van Vliet M.H., Eijsman L., Wildevuur C.R. Endotoxin release and tumor necrosis factor formation during cardiopulmonary bypass. The Annals of thoracic surgery 1992, 54(4):744-747. [discussion 747-748.].
6. Riddington D.W., Venkatesh B., Boivin C.M., Bonser R.S., Elliott T.S., Marshall T., et al. Intestinal permeability, gastric intramucosal pH, and systemic endotoxemia in patients undergoing cardiopulmonary bypass. JAMA 1996, 275(13):1007-1012.
7. Edwards J.D. Oxygen transport in cardiogenic and septic shock. Crit Care Med 1991, 19(5):658-663.
8. Vallee F., Vallet B., Mathe O., Parraguette J., Mari A., Silva S., et al. Central venous-to-arterial carbon dioxide difference: an additional target for goal-directed therapy in septic shock?. Intensive Care Med 2008, 34(12):2218-2225.
9. Garrett S.A., Pearl R.G. Improved gastric tonometry for monitoring tissue perfusion: the canary sings louder. Anesth Analg 1996, 83(1):1-3.
10. Fiddian-Green R.G. Monitoring of tissue pH: the critical measurement. Chest 1999, 116(6):1839-1841.
11. Palizas F., Dubin A., Regueira T., Bruhn A., Knobel E., Lazzeri S., et al. Gastric tonometry versus cardiac index as resuscitation goals in septic shock: a multicenter, randomized, controlled trial. Crit Care 2009, 13(2):R44.
12. Huang C.C., Tsai Y.H., Lin M.C., Tsao T.C., Hsu K.H. Gastric intramucosal PCO2 and pH variability in ventilated critically ill patients. Crit Care Med 2001, 29(1):88-95.
13. Giglio M.T., Marucci M., Testini M., Brienza N. Goal-directed haemodynamic therapy and gastrointestinal complications in major surgery: a meta-analysis of randomized controlled trials. Br J Anaesth 2009, 103(5):637-646.
14. Schwenzer K.J., Kopel R.F. Hemodynamic and metabolic effects of dobutamine in 18 patients after open heart surgery. Crit Care Med 1990, 18(10):1107-1110.
15. Stoner J.D., Bolen J.L., Harrison D.C. Comparison of dobutamine and dopamine in treatment of severe heart failure. Br Heart J 1977, 39(5):536-539.
16. Goldberg L.I., Rajfer S.I. Dopamine receptors: applications in clinical cardiology. Circulation 1985, 72(2):245-248.
17. Creteur J., De Backer D., Vincent J.L. A dobutamine test can disclose hepatosplanchnic hypoperfusion in septic patients. Am J Respir Crit Care Med 1999, 160(3):839-845.
18. MacGregor D.A., Butterworth J.F.T., Zaloga C.P., Prielipp R.C., James R., Royster R.L. Hemodynamic and renal effects of dopexamine and dobutamine in patients with reduced cardiac output following coronary artery bypass grafting. Chest 1994, 106(3):835-841.
19. Rosenthal M.H. Intraoperative fluid management-what and how much?. Chest 1999, 115(5 Suppl):106S-112S.
20. Carrico C.J., Meakins J.L., Marshall J.C., Fry D., Maier R.V. Multiple-organ-failure syndrome. Arch Surg 1986, 121(2):196-208.
21. Deitch E.A., Berg R., Specian R. Endotoxin promotes the translocation of bacteria from the gut. Arch Surg 1987, 122(2):185-190.
22. Gutierrez G., Palizas F., Doglio G., Wainsztein N., Gallesio A., Pacin J., et al. Gastric intramucosal pH as a therapeutic index of tissue oxygenation in critically ill patients. Lancet 1992, 339(8787):195-199.
23. Shoemaker W.C., Appel P.L., Kram H.B., Waxman K., Lee T.S. Prospective trial of supranormal values of survivors as therapeutic goals in high-risk surgical patients. Chest 1988, 94(6):1176-1186.
24. Hayes M.A., Timmins A.C., Yau E.H., Palazzo M., Hinds C.J., Watson D. Elevation of systemic oxygen delivery in the treatment of critically ill patients. N Engl J Med 1994, 330(24):1717-1722.
25. Heyland D.K., Cook D.J., King D., Kernerman P., Brun-Buisson C. Maximizing oxygen delivery in critically ill patients: a methodologic appraisal of the evidence. Crit Care Med 1996, 24(3):517-524.
26. Durham R.M., Neunaber K., Mazuski J.E., Shapiro M.J., Baue A.E. The use of oxygen consumption and delivery as endpoints for resuscitation in critically ill patients. The Journal of trauma 1996, 41(1):32-39. [discussion 39-40].
27. Vernon D.D., Garrett J.S., Banner W., Dean J.M. Hemodynamic effects of dobutamine in an intact animal model. Crit Care Med 1992, 20(9):1322-1329.
28. de Souza R.L., de Carvalho W.B., Maluf M.A., Carvalho A.C. Assessment of splanchnic perfusion with gastric tonometry in the immediate postoperative period of cardiac surgery in children. Arq Bras Cardiol 2001, 77(6):509-519.
29. Agusti M., Elizalde J.I., Adalia R., Martinez-Palli G., Garcia-Valdecasas J.C., Pique J.M., et al. The effects of vasoactive drugs on hepatic blood flow changes induced by CO2 laparoscopy: an animal study. Anesth Analg 2001, 93(5):1121-1126.
30. Raddatz A., Kubulus D., Winning J., Bauer I., Pradarutti S., Wolf B., et al. Dobutamine improves liver function after hemorrhagic shock through induction of heme oxygenase-1. Am J Respir Crit Care Med 2006, 174(2):198-207.
31. Neviere R., Chagnon J.L., Vallet B., Lebleu N., Marechal X., Mathieu D., et al. Dobutamine improves gastrointestinal mucosal blood flow in a porcine model of endotoxic shock. Crit Care Med 1997, 25(8):1371-1377.
32. Vincent J.L., Van der Linden P., Domb M., Blecic S., Azimi G., Bernard A. Dopamine compared with dobutamine in experimental septic shock: relevance to fluid administration. Anesth Analg 1987, 66(6):565-571.
33. Fink M.P., Kaups K.L., Wang H.L., Rothschild H.R. Maintenance of superior mesenteric arterial perfusion prevents increased intestinal mucosal permeability in endotoxic pigs. Surgery 1991, 110(2):154-160. [discussion 160-151].
34. Secchi A., Wellmann R., Martin E., Schmidt H. Dobutamine maintains intestinal villus blood flow during normotensive endotoxemia: an intravital microscopic study in the rat. J Crit Care 1997, 12(3):137-141.
35. Germann R., Haisjackl M., Schwarz B., Deusch E., Meusburger S., Gruber E., et al. Inotropic treatment and intestinal mucosal tissue oxygenation in a model of porcine endotoxemia. Crit Care Med 1997, 25(7):1191-1197.
36. Nordin A.J., Makisalo H., Hockerstedt K.A. Failure of dobutamine to improve liver oxygenation during resuscitation with a crystalloid solution after experimental haemorrhagic shock. Eur J Surg Acta chirurgica 1996, 162(12):973-979.
37. Muller M., Boldt J., Schindler E., Sticher J., Kelm C., Roth S., et al. Effects of low-dose dopexamine on splanchnic oxygenation during major abdominal surgery. Crit Care Med 1999, 27(11):2389-2393.
38. Lobo S.M., Lobo F.R., Polachini C.A., Patini D.S., Yamamoto A.E., de Oliveira N.E., et al. Prospective, randomized trial comparing fluids and dobutamine optimization of oxygen delivery in high-risk surgical patients. Crit Care 2006, 10(3):R72. [ISRCTN42445141].
39. Levy B., Bollaert P.E., Lucchelli J.P., Sadoune L.O., Nace L., Larcan A. Dobutamine improves the adequacy of gastric mucosal perfusion in epinephrine-treated septic shock. Crit Care Med 1997, 25(10):1649-1654.
40. Miller P.R., Kincaid E.H., Meredith J.W., Chang M.C. Threshold values of intramucosal pH and mucosal-arterial CO2 gap during shock resuscitation. J Trauma 1998, 45(5):868-872.
41. Mythen M.G., Webb A.R. Intra-operative gut mucosal hypoperfusion is associated with increased post-operative complications and cost. Intensive Care Med 1994, 20(2):99-104.